Trends in blood pressure changes and hypertension prevalence in Australian adults before and during the COVID-19 pandemic.

"CONFLICT OF INTEREST STATEMENT Janis M. Nolde and the other authors declare that they have no conflict of interest. Fleur Streets, Jiajun Wei, and Patrick Hannebery are employed by the SISU Health Group, Melbourne. Gavin W. Lambert has received consulting fees, and/or travel and research support from Pfizer, Wyeth Pharmaceuticals, Servier, and Medtronic. Markus P. Schlaich was supported by an NHMRC Research Fellowship and has received consulting fees, and/or travel and research support from Medtronic, Abbott, ReCor, Novartis, Servier, Pfizer, and Boehringer‐Ingelheim. Australian Pharmaceutical Industries (API Ltd) maintains a minor shareholding in SiSU Health Group. API is now fully owned by Wesfarmers Ltd and forms part of the Wesfarmers Health division."

"This work was supported by resources provided by the Pawsey Supercomputing Centre with funding from the Australian Government and the Government of Western Australia. Further support was provided by Swinburne Research (Swinburne University of Technology)."